Sanofi Consumer Healthcare India Ltd.
•Add ratio to table
ABOUT
AI Sector View
AI GENERATEDHealthcare
This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.
PROS
- Company is almost debt free
- Company has a healthy return on capital (ROCE) of 102.7%
- Company has a good return on equity (ROE) track record: 3 Years ROE 80.6%
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.05x)
- Company generates healthy free cash flow
CONS
- Receivables are growing faster than sales - a possible quality concern
- Stock is trading at 27.1x its book value
- Recurring exceptional / one-off items are inflating headline profit
- Rich enterprise valuation - EV/EBITDA of 30.7x
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
| Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| SUNPHARMA | 1864.00 | 36.98 | 447236.04 | 0.86 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| DIVISLAB | 9405.00 | 85.36 | 249673.20 | 0.32 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| TORNTPHARM | 4928.40 | 85.95 | 187460.49 | 0.77 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| ZYDUSLIFE | 1118.00 | 24.71 | 111520.93 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| CIPLA | 1380.00 | 33.08 | 111484.47 | 0.94 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| LAURUSLABS | 1936.00 | 95.67 | 104604.45 | 0.10 | 362.07 | 123.94 | 2026.31 | 29.10 | 18.20 | 31.50 |
| AUROPHARMA | 1669.00 | 25.87 | 96030.57 | 0.24 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| DRREDDY | 1140.80 | 29.55 | 95220.28 | 0.70 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| LUPIN | 2075.00 | 17.16 | 94882.67 | 0.87 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| MANKIND | 2246.00 | 45.42 | 92769.93 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| GLENMARK | 2417.00 | 37.94 | 68213.70 | 0.10 | 482.83 | 927.88 | 4018.48 | 31.35 | 20.35 | 20.03 |
| SANOFICONR | 4109.40 | 35.58 | 9464.20 | 1.83 | 68.80 | 13.34 | 235.70 | 6.70 | 98.11 | 37.89 |
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100 | 210 | 225 | 222 | 172 | 160 | 171 | 173 | 221 | 234 | 251 | 229 | 236 | |
| 66 | 116 | 135 | 140 | 109 | 97 | 109 | 109 | 151 | 149 | 161 | 140 | 150 | |
| Operating Profit | 35 | 95 | 90 | 82 | 64 | 63 | 62 | 64 | 70 | 85 | 90 | 89 | 86 |
| OPM % | 34.60% | 44.98% | 39.85% | 36.91% | 36.91% | 39.46% | 36.38% | 37.08% | 31.78% | 36.34% | 35.78% | 38.74% | 36.32% |
| 0 | 1 | 1 | 3 | -24 | 3 | 2 | 5 | 12 | 3 | 5 | 6 | 6 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Depreciation | 0 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 3 | 3 | 3 | 3 | 3 |
| Profit before Tax | 34 | 95 | 90 | 84 | 39 | 61 | 63 | 67 | 79 | 84 | 90 | 91 | 92 |
| Tax % | 25.22% | 25.21% | 24.22% | 25.27% | 25.45% | 26.47% | 29.46% | 25.15% | 23.07% | 25.21% | 26.52% | 25.25% | 25.14% |
| Net Profit | 26 | 71 | 68 | 63 | 29 | 45 | 44 | 50 | 61 | 63 | 66 | 68 | 69 |
| 11.19 | 30.92 | 29.48 | 27.22 | 12.58 | 19.52 | 19.25 | 21.69 | 26.36 | 27.31 | 28.87 | 29.44 | 29.87 |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Dec 2023 | Dec 2024 | Dec 2025 | TTM | |
|---|---|---|---|---|
| 555 | 724 | 878 | 950 | |
| 337 | 454 | 569 | 601 | |
| Operating Profit | 219 | 271 | 309 | 349 |
| OPM % | 39.40% | 37.35% | 35.18% | 36.77% |
| 2 | -15 | 25 | 20 | |
| Interest | 0 | 4 | 2 | 2 |
| Depreciation | 2 | 4 | 12 | 13 |
| Profit before Tax | 219 | 247 | 320 | 357 |
| Tax % | 24.81% | 26.66% | 25.04% | 25.53% |
| Net Profit | 165 | 181 | 240 | 266 |
| EPS | 824.50 | 78.70 | 104.39 | — |
| Dividend Payout % | 6.06% | 69.89% | 71.85% | — |
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- -22%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 81%
- Last Year:
- 73%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|
| Equity Capital | 2 | 23 | 23 |
| 183 | 249 | 361 | |
| 0 | 17 | 17 | |
| Trade Payables | 60 | 70 | 80 |
| 99 | 188 | 262 | |
| Total Liabilities | 344 | 547 | 742 |
| 5 | 29 | 36 | |
| Capital Work in Progress | 0 | 1 | 0 |
| 97 | 41 | 62 | |
| 32 | 14 | 30 | |
| Cash & Bank | 2 | 327 | 375 |
| 209 | 135 | 240 | |
| Total Assets | 344 | 547 | 742 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|
| -0 | 439 | 175 | |
| Cash from Investing | 0 | 2 | 8 |
| Cash from Financing | 2 | -116 | -134 |
| 2 | 325 | 48 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|
Documents
Corporate disclosures, annual reports, credit ratings, and concall transcripts
2026-07-30 - Sanofi Consumer Healthcare India Limited has informed the Exchange about Copy of Newspaper Publication of Unaudited Financial Result for the quarter and half year ended 30th June 2026.
2026-07-28 - Sanofi Consumer Healthcare India Limited has informed the Exchange regarding a press release dated July 28, 2026.
2026-07-28 - Sanofi Consumer Healthcare India Limited has submitted to the Exchange, the Unaudited Financial Results for the quarter and half year ended Jun 30, 2026.
2026-07-09 - Sanofi Consumer Healthcare India Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
2026-06-29 - Sanofi Consumer Healthcare India Limited has informed the Exchange regarding Change in Auditors of the company.
2026-06-29 - Sanofi Consumer Healthcare India Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on Jun 26, 2026. Further, the company has informed the Exchange regarding voting results.
2026-06-26 - Sanofi Consumer Healthcare India Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on June 26, 2026
2026-06-26 - Sanofi Consumer Healthcare India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
2026-06-05 - Sanofi Consumer Healthcare India Limited has informed the Exchange about Copy of Newspaper Publication of 3rd Annual General Meeting of the Company
News
Recent coverage and analyst commentary for SANOFICONR
Loading news…
AI Stock Analyst
Sanofi Consumer Healthcare India Ltd.
Sign in to Chat with AI
Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.
✨ Sign In to ChatFree 5nance Account